主要文件

查看所有文档

Z-004

扎来普隆标准液溶液

Name: 扎来普隆标准液 溶液
Brand: CERILLIAN

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₇H₁₅N₅O

化学文摘社编号:

151319-34-5

分子量:

305.33

NACRES:

NA.24

UNSPSC Code:

41116107

EC Number:

200-659-6

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

grade

certified reference material

Quality Level

300

form

liquid

feature

Snap-N-Spike^®/Snap-N-Shoot^®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant^®

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

SMILES string

CCN(C(C)=O)c1cccc(c1)-c2ccnc3c(cnn23)C#N

InChI

1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3

InChI key

HUNXMJYCHXQEGX-UHFFFAOYSA-N

Gene Information

human ... GABRA1(2554), GABRB1(2560), GABRG2(2566)

说明

General description

扎来普隆是一种非苯二氮卓类“Z药”，商品名为Sonata^®或Starnoc，用于治疗失眠。扎来普隆经常因其改变精神的作用而被非法滥用。该经认证的加标溶液^®适用于尿液药物检测、临床毒理学和法医分析的LC/MS或GC/MS应用。

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Sonata is a registered trademark of King Pharmaceuticals Research and Development, Inc.

pictograms

GHS02,GHS06,GHS08

signalword

Danger

hcodes

H225,H301 + H311 + H331,H370

pcodes

P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes

存储类别

3 - Flammable liquids

wgk

WGK 1

flash_point_f

49.5 °F - closed cup

flash_point_c

9.7 °C - closed cup

法规信息

监管及禁止进口产品

此项目有

分析证书(COA)

输入产品批号来搜索分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.

Yu-Shu Huang et al.

Chang Gung medical journal, 34(1), 50-56 (2011-03-12)

Benzodiazepines cause a high proportion of adverse effects while non-benzodiazepine compounds have demonstrated high efficacy and less adverse effects in patients with insomnia. The objective of this study was to compare the effectiveness and safety of non-BZ zaleplon and zolpidem

A case of zaleplon-induced amnestic sleep-related eating disorder.

Shanna M Molina et al.

The Journal of clinical psychiatry, 71(2), 210-211 (2010-03-03)

Insomnia: evidence-based approaches to assessment and management.

Kevin Morgan et al.

Clinical medicine (London, England), 11(3), 278-281 (2011-09-10)

查看所有相关文献

全球贸易项目编号

货号	GTIN
Z-004-1ML	04061837588259

主要文件

扎来普隆标准液溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®